Fieldex Exploration to acquire Copeland Biosciences.

Synopsis

Fieldex Exploration, a Canadian mineral exploration firm, to acquire Copeland Biosciences, a cannabis pharma company, in a reverse takeover transaction. Upon the deal closure, Fieldex will be listed on the Canadian Securities Exchange and will be renamed Copeland Biosciences Corp.

Principals

target

Copeland Biosciences

bidder

Fieldex Exploration

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Dealmakers (2)

Service Providers

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.